Account
ASCI awards PR and digital mandate to Pitchfork Partners
MUMBAI: The Advertising Standards Council of India (ASCI) has appointed Pitchfork Partners Strategic Consulting as its public relations and digital counsel following a multi-agency pitch. Pitchfork Partners will ensure effective communication navigation for ASCI’s stakeholders to strengthen its position as an organisation dedicated to safeguarding consumers’ interests.
ASCI is a self-regulated voluntary organisation that ensures responsible advertising. ASCI positively impacts society with its quick decision making and the accountability taken by brands towards the issues it raises for consumers’ benefit.
ASCI chairman Rohit Gupta said: “When it came to choosing our communication partner, we wanted people who could synergise with ASCI’s vision and direction, refresh its communication and ensure that our connection with consumers strengthens more than ever before. We are delighted to have Pitchfork Partners as our communication experts. Pitchfork’s young team and expertise will help us achieve our mission.”
Pitchfork Partners co-founder Jaideep Shergill said: “We are elated to partner with ASCI. With the growth in miscommunication through advertisements which in turn harms the consumer, especially in these times, ASCI has a very important role to play. The new consumer protection regulations mean great empowerment for consumers. This is an opportunity for ASCI to make an even stronger impact and underscore its leadership role in consumer protection and responsible advertising. Pitchfork Partners will assist ASCI through its strategic counsel in this effort.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
